Price $15.09 |
Market Cap
241.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
59.3
|
P/B
7.78
|
P/S
2.7
|
Dividend %
-
|
|
P/CF
300.4
|
P/FCF
39.3
|
Op. Cash Flow
13.4K
|
FCF
0.4
|
|
Op. Margin
3.70%
|
Net Margin
4.70%
|
ROE
14.10%
|
ROI
21.00%
|
|
ROA
4.90%
|
EPS Growth
-72.70%
|
Current Ratio
1.3
|
Debt/Equity
7.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Chembio Diagnostics Inc (CEMI) | $0.65 | - | - | 22.7M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $2.10 | - | - | 30.9M | Strong Buy |
| Lannett Company, Inc. (LCI) | $0.58 | - | - | 22.4M | Strong Buy |
| Assertio Holdings Inc (ASRT) | $2.73 | - | - | 136.8M | Strong Buy |
| Cyclo Therapeutics Inc (CYTH) | $2.10 | - | - | 19.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
